- 2025,07,17
Report from our correspondent (reporter wuyixuan) on July 2, the concept stocks of marine biomedicine in the A-share market performed actively. Among them, Zhejiang Zhenyi Pharmaceutical (603811) Co., Ltd. (hereinafter referred to as "Zhenyi pharmaceutical") is a listed company deeply engaged in marine biomedicine, which rose sharply at the opening. As of the closing, the company's share price rose 10.00% to 10.45 yuan/share.
It is reported that sincerity pharmaceutical has been actively integrated into the national marine strategy, with the two core businesses of ammonia sugar and fish oil, deeply layout the field of marine biomedicine, showing a strong momentum of development. In the marine biomedicine industry chain, sincerity pharmaceutical has become the "leader" of the industry with nearly 70% of the revenue of marine biomedicine. At the same time, sincerity pharmaceutical also launched an innovative layout in the field of fish oil. The company actively promoted the construction of EPA API project of high-purity fish oil with the marine biomedical manufacturing project as the carrier. The relevant person in charge of sincerity pharmaceutical said that at present, the company is in good operation and its business is developing steadily.
Source: Securities Daily